An interventional study of ID-JPL934 and Placebo in Abnormal Bowel Movement Such as Constipation, Diarrhea, Abdominal Pain, sponsored by Seoul National University Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 19 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-01-30.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
Probiotics, which are part of the human body, are microorganisms, which are known to have beneficial effects when consumed in a certain amount, and have the function of controlling intestinal flora and inhibiting inflammation. Recently, probiotics have received much attention in the treatment of hypersensitivity syndrome. The aim of this study was to investigate the effect of probiotic strains, ID-JPL934, in the diagnosis of irritable bowel syndrome.
Overall satisfaction with improvement of bowel habits such as diarrhea and constipation as well as abdominal discomfort and abdominal discomfort in the group receiving ID-JPL934 capsules (test food group or test group) and control group (control food group or control group) (0-10 point visual analogue scale) for each symptom before and after ingestion to evaluate the degree of improvement of the symptoms. The purpose of this study was to investigate the relationship between bacterial composition changes in the stool and the improvement of symptoms in the patients before and after ingestion.
Exclusion Criteria:
probiotics 20%, corn starch 80%
Dietary Supplement: ID-JPL934
corn starch 100%
Dietary Supplement: Placebo
probiotics
corn starch
symptom improvement effect
symptom questionnaire survey
Time frame: 8week
VAS score
Visual analogue scale score(10-point scales)
Time frame: 8week
QoL score
Quality of Life score (5-point scales)
Time frame: 8week
Plan to share: No
This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital